Jonathan Jay Mazelsky - 05 Aug 2021 Form 4 Insider Report for IDEXX LABORATORIES INC /DE (IDXX)

Role
President & CEO, Director
Signature
/s/ Lily J. Lu, Attorney-in-Fact for Jonathan Jay Mazelsky
Issuer symbol
IDXX
Transactions as of
05 Aug 2021
Net transactions value
-$126,331
Form type
4
Filing time
09 Aug 2021, 17:01:21 UTC
Previous filing
20 May 2021
Next filing
17 Aug 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IDXX Common Stock Options Exercise $0 +385 +0.7% $0.000000 55,606 05 Aug 2021 Direct F1
transaction IDXX Common Stock Tax liability $126,331 -179 -0.32% $705.76 55,427 05 Aug 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IDXX Restricted Stock Unit Options Exercise -385 -3.9% 9,605 05 Aug 2021 Common Stock 385 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 11.6426 shares acquired under the IDEXX Laboratories, Inc. Employee Stock Purchase Plan on June 30, 2021.
F2 Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning August 5, 2020.
F3 Not applicable.